Skip to content

Precigen PGEN Quick ratio

Quick ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.3×+0.1×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-1.1×
Gilead Sciences logo
Gilead SciencesGILD
1.7×+0.5×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
15.1×-4.3×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
13.6×-4.3×
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
32.6×+16.8×

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.93B+213%

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on the most recent quarter.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's quick ratio?
Precigen (PGEN) reported quick ratio of 4.1× in Q1 2026.
How has Precigen's quick ratio changed year-over-year?
Precigen's quick ratio increased by 16.8% year-over-year, from 3.5× to 4.1×.
What is the long-term trend for Precigen's quick ratio?
Over 5 years (2020 to 2025), Precigen's quick ratio has grown at a -2.8% compound annual growth rate (CAGR), from 3.3× to 2.8×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.